Both in Surgical Instruments
Delcath Systems vs Neuropace
Over the past year DCTH returned +51.3% and NPCE returned +31.0%; their daily moves had a correlation of 0.22.
DCTH +51.3% NPCE +31.0%Growth of $1, one year, split-adjusted
| Metric | DCTH | NPCE |
|---|---|---|
| Price | $14.40 | $12.31 |
| Market cap | $499.7M | $422.5M |
| Today | +0.77% | −0.24% |
| 1 month | −9.3% | −6.9% |
| 6 months | +24.9% | −27.8% |
| Year to date | +42.6% | −20.3% |
| 1 year | +46.5% | +23.8% |
| Revenue growth (YoY) | +20.6% | +17.1% |
| Gross margin | 89.8% | 82.8% |
| Net margin | 9.2% | −27.2% |
| P/E (TTM) | 939.2× | — |
| Price / sales | 5.2× | 4.3× |
| Net cash | $95.9M | -$7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 32.9% | 40.2% |
| Short % of float | 7.1% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).